Cargando…
Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey
BACKGROUND: Cell-free DNA (cfDNA) screening has recently acquired tremendous attention, promising patients and healthcare providers a more accurate prenatal screen for aneuploidy than other current screening modalities. It is unclear how much knowledge regarding cfDNA screening obstetrical providers...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781306/ https://www.ncbi.nlm.nih.gov/pubmed/29361931 http://dx.doi.org/10.1186/s12884-018-1662-z |
_version_ | 1783294925186531328 |
---|---|
author | Chan, Wilson V. Johnson, Jo-Ann Wilson, R. Douglas Metcalfe, Amy |
author_facet | Chan, Wilson V. Johnson, Jo-Ann Wilson, R. Douglas Metcalfe, Amy |
author_sort | Chan, Wilson V. |
collection | PubMed |
description | BACKGROUND: Cell-free DNA (cfDNA) screening has recently acquired tremendous attention, promising patients and healthcare providers a more accurate prenatal screen for aneuploidy than other current screening modalities. It is unclear how much knowledge regarding cfDNA screening obstetrical providers possess which has important implications for the quality and content of the informed consent patients receive. METHODS: A survey was designed to assess obstetrical provider knowledge and attitudes towards cfDNA screening and distributed online through the Society of Obstetricians & Gynecologists of Canada (SOGC). Chi-squared tests were used to detect differences in knowledge and attitudes between groups. RESULTS: 207 respondents completed the survey, composed of 60.6% Obstetricians/Gynecologists (OB/GYN), 15.4% Maternal Fetal Medicine (MFM) specialists, 16.5% General Practitioners (GP), and 7.5% Midwives (MW). MFM demonstrated a significant trend of being most knowledgeable about cfDNA screening followed by OB/GYN, GP, and lastly MW in almost all aspects of cfDNA screening. All groups demonstrated an overall positive attitude towards cfDNA screening; however, OB/GYN and MFM demonstrated a significantly more positive attitude than GP and MW. Despite not yet being a diagnostic test, 19.4% of GP would offer termination of pregnancy immediately following a positive cfDNA screen result compared to none of the MFM and only few OB/GYN or MW. CONCLUSIONS: We have demonstrated that different types of obstetrical providers possess varying amounts of knowledge regarding cfDNA screening with MFM currently having greater knowledge to all other groups. All obstetrical providers must have adequate prenatal screening understanding so that we can embrace the benefits of this novel and promising technology while protecting the integrity of the informed consent process. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-018-1662-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5781306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57813062018-02-06 Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey Chan, Wilson V. Johnson, Jo-Ann Wilson, R. Douglas Metcalfe, Amy BMC Pregnancy Childbirth Research Article BACKGROUND: Cell-free DNA (cfDNA) screening has recently acquired tremendous attention, promising patients and healthcare providers a more accurate prenatal screen for aneuploidy than other current screening modalities. It is unclear how much knowledge regarding cfDNA screening obstetrical providers possess which has important implications for the quality and content of the informed consent patients receive. METHODS: A survey was designed to assess obstetrical provider knowledge and attitudes towards cfDNA screening and distributed online through the Society of Obstetricians & Gynecologists of Canada (SOGC). Chi-squared tests were used to detect differences in knowledge and attitudes between groups. RESULTS: 207 respondents completed the survey, composed of 60.6% Obstetricians/Gynecologists (OB/GYN), 15.4% Maternal Fetal Medicine (MFM) specialists, 16.5% General Practitioners (GP), and 7.5% Midwives (MW). MFM demonstrated a significant trend of being most knowledgeable about cfDNA screening followed by OB/GYN, GP, and lastly MW in almost all aspects of cfDNA screening. All groups demonstrated an overall positive attitude towards cfDNA screening; however, OB/GYN and MFM demonstrated a significantly more positive attitude than GP and MW. Despite not yet being a diagnostic test, 19.4% of GP would offer termination of pregnancy immediately following a positive cfDNA screen result compared to none of the MFM and only few OB/GYN or MW. CONCLUSIONS: We have demonstrated that different types of obstetrical providers possess varying amounts of knowledge regarding cfDNA screening with MFM currently having greater knowledge to all other groups. All obstetrical providers must have adequate prenatal screening understanding so that we can embrace the benefits of this novel and promising technology while protecting the integrity of the informed consent process. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-018-1662-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-23 /pmc/articles/PMC5781306/ /pubmed/29361931 http://dx.doi.org/10.1186/s12884-018-1662-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Chan, Wilson V. Johnson, Jo-Ann Wilson, R. Douglas Metcalfe, Amy Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey |
title | Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey |
title_full | Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey |
title_fullStr | Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey |
title_full_unstemmed | Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey |
title_short | Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey |
title_sort | obstetrical provider knowledge and attitudes towards cell–free dna screening: results of a cross-sectional national survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781306/ https://www.ncbi.nlm.nih.gov/pubmed/29361931 http://dx.doi.org/10.1186/s12884-018-1662-z |
work_keys_str_mv | AT chanwilsonv obstetricalproviderknowledgeandattitudestowardscellfreednascreeningresultsofacrosssectionalnationalsurvey AT johnsonjoann obstetricalproviderknowledgeandattitudestowardscellfreednascreeningresultsofacrosssectionalnationalsurvey AT wilsonrdouglas obstetricalproviderknowledgeandattitudestowardscellfreednascreeningresultsofacrosssectionalnationalsurvey AT metcalfeamy obstetricalproviderknowledgeandattitudestowardscellfreednascreeningresultsofacrosssectionalnationalsurvey |